Biocon and Alkem Labs gain after USFDA approvals
DSIJ Intelligence / 15 Mar 2017
BSE healthcare index is up by nearly 0.5% on intraday basis. Sanofi is the top index gainer in BSE Healthcare index along with Cadila Healthcare; up by 3% and 2.8% respectively. Fortis is up by 2.5%.Jubilant is down by nearly 2%. Hikal is down by 1.8% , FDC down by 1.73% and Suven is down by 1.10%.
Biocon and Alkem Labs gained on Wednesday by more than 3% on intraday basis after these companies obtained the approvals from US drug regulator.
After US Food and Drug Administration (USFDA) approved Mylan’s Exemestane tablets which is used to treat breast cancer, Biocon was seen gaining on Wednesday.
Alkem Labs also saw some positive traction in trade after the US FDA approved Lidocaine ointment, which is used to treat ventricular tachycardia.
Meanwhile, Alkem Labs received the nod from the regulator for Lidocaine ointment, which is to treat ventricular tachycardia.
BSE healthcare index is up by nearly 0.5% on intraday basis.Sanofi is the top index gainer in BSE Healthcare index along with Cadila Healthcare; up by 3% and 2.8% respectively. Fortis is up by 2.5%. Jubilant is down by nearly 2%. Hikal is down by 1.8% , FDC down by 1.73% and Suven Lifescience is down by 1.10%.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.